Mannitol Injection 10 %

๐Ÿ’‰ Mannitol Injection 10% โ€“ As Licensed


๐Ÿ“„ Description:

Mannitol 10% Injection is a sterile, non-pyrogenic solution of mannitol, a type of osmotic diuretic and renal diagnostic aid. It is used to reduce intracranial pressure, intraocular pressure, and promote diuresis in cases of acute kidney failure or drug toxicity.


๐Ÿงพ Prescription / Use:

Indications:

  • Cerebral edema / increased intracranial pressure
  • Acute glaucoma (reducing intraocular pressure)
  • Promote diuresis in acute renal failure
  • Prevent renal damage from toxic substances
  • Used in renal function testing

Dosage:

  • Depends on clinical condition and weight
  • 0.25โ€“2 g/kg IV over 30โ€“60 minutes
  • Dose and rate adjusted based on urine output, renal function, and response

Route: Intravenous (IV) infusion
Strength: 10% = 10 g Mannitol per 100 mL


๐Ÿ”ฌ Nature:

  • Class: Osmotic diuretic
  • Mechanism: Increases plasma osmolality, drawing water from tissues into blood and enhancing urine output
  • Effect: Reduces pressure in brain and eyes, enhances elimination of toxins via kidneys

๐ŸŒŸ Advantages:

  • Rapid reduction of intracranial and intraocular pressure
  • Helps in preventing or managing acute renal failure
  • Clears nephrotoxic substances
  • Useful in emergency neurosurgical or ophthalmologic settings

๐Ÿ“ฆ Common Packaging:

  • Available in glass or plastic infusion bottles/vials
  • Standard volume: 100 mL, 250 mL, 500 mL
  • Clearly labeled with concentration, batch, expiry, and sterility assurance

๐ŸงŠ Storage:

  • Store at 20ยฐC to 25ยฐC (room temperature)
  • Do not refrigerate, as crystallization may occur
  • If crystals form, warm the solution and shake to dissolve
  • Use only if solution is clear and free from particles

โš ๏ธ Precautions:

Contraindications:

  • Established anuria (no urine production)
  • Severe dehydration
  • Active intracranial bleeding (unless during craniotomy)
  • Pulmonary edema or heart failure
  • Known hypersensitivity

Use with caution in:

  • Renal impairment
  • Cardiac patients (can cause fluid overload)
  • Electrolyte imbalances

Monitoring:

  • Serum electrolytes (Na+, K+)
  • Renal function tests (BUN, creatinine)
  • Urine output
  • Serum osmolality
  • Signs of volume overload (edema, lung crepitations)

๐Ÿ‘ฉโ€โš•๏ธ Patient Advice:

  • Administered only in hospital or clinical settings
  • Patients may experience headache, nausea, or chills during infusion
  • Notify staff of symptoms like chest discomfort, shortness of breath, or low urine output
  • Do not self-administer; requires strict monitoring
  • Avoid fluid overload โ€“ intake is often restricted during use

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button